In March 2020, we performed a multicenter, randomized, double-blind phase II study of mesenchymal stem cells (MSCs) therapy in patients with severe COVID-19 (ClinicalTrials.gov: NCT04288102). Findings showed that MSC was a potentially effective therapeutic approach for patients with severe COVID-19,...
A total of 62022 unique peptides were acquired, and 7137 proteins were confidently identified and quantified inthe cryptic (CT) and contralateral (CLT) testis from four unilaterally cryptorchid rams
